1. Home
  2. ACAD vs NAD Comparison

ACAD vs NAD Comparison

Compare ACAD & NAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACAD
  • NAD
  • Stock Information
  • Founded
  • ACAD 1993
  • NAD 1999
  • Country
  • ACAD United States
  • NAD United States
  • Employees
  • ACAD N/A
  • NAD N/A
  • Industry
  • ACAD Biotechnology: Pharmaceutical Preparations
  • NAD Investment Managers
  • Sector
  • ACAD Health Care
  • NAD Finance
  • Exchange
  • ACAD Nasdaq
  • NAD Nasdaq
  • Market Cap
  • ACAD 2.8B
  • NAD 2.7B
  • IPO Year
  • ACAD 2004
  • NAD N/A
  • Fundamental
  • Price
  • ACAD $17.57
  • NAD $11.67
  • Analyst Decision
  • ACAD Buy
  • NAD
  • Analyst Count
  • ACAD 19
  • NAD 0
  • Target Price
  • ACAD $26.17
  • NAD N/A
  • AVG Volume (30 Days)
  • ACAD 4.3M
  • NAD 595.7K
  • Earning Date
  • ACAD 02-25-2025
  • NAD 01-01-0001
  • Dividend Yield
  • ACAD N/A
  • NAD 4.35%
  • EPS Growth
  • ACAD N/A
  • NAD N/A
  • EPS
  • ACAD 0.78
  • NAD N/A
  • Revenue
  • ACAD $929,236,000.00
  • NAD N/A
  • Revenue This Year
  • ACAD $36.78
  • NAD N/A
  • Revenue Next Year
  • ACAD $8.19
  • NAD N/A
  • P/E Ratio
  • ACAD $22.63
  • NAD N/A
  • Revenue Growth
  • ACAD 47.06
  • NAD N/A
  • 52 Week Low
  • ACAD $14.15
  • NAD $9.56
  • 52 Week High
  • ACAD $29.29
  • NAD $11.64
  • Technical
  • Relative Strength Index (RSI)
  • ACAD 52.06
  • NAD 43.64
  • Support Level
  • ACAD $16.61
  • NAD $11.59
  • Resistance Level
  • ACAD $18.23
  • NAD $11.74
  • Average True Range (ATR)
  • ACAD 0.74
  • NAD 0.11
  • MACD
  • ACAD -0.05
  • NAD 0.01
  • Stochastic Oscillator
  • ACAD 36.59
  • NAD 46.43

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

About NAD Nuveen Quality Municipal Income Fund

Nuveen Quality Municipal Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide current income exempted from regular federal income tax by investing in tax-exempt municipal securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: